Eleuteri, Simona, Bao Wang, Gianni Cutillo, Tracy Shi Zhang Fang, Kai Tao, Yan Qu, Qian Yang, Wenyi Wei, and David K Simon. 2024. “PGC-1α Regulation by FBXW7 through a Novel Mechanism Linking Chaperone-Mediated Autophagy and the Ubiquitin-Proteasome System”. The FEBS Journal.
Publications
2024
2023
XS, Ding, Gao L, Han Z, Shi W, Shen Y, Song ZY, Su M, et al. 2023. “Ferroptosis in Parkinson’s Disease: Molecular Mechanisms and Therapeutic Potential”. Ageing Research Reviews.
Eleuteri, Simona, Tracy Shi Zhang Fang, Gianni Cutillo, Michele Persico, and David K Simon. 2023. “Retromer Stabilization Using a Pharmacological Chaperone Protects in an α-Synuclein Based Mouse Model of Parkinson’s”. Research Square (Preprint).
Ditzel, RM, RH Walker, MJ Nirenberg, AM Tetlow, K Farrell, KJ Lind-Watson, EL Thorn, et al. 2023. “Sphingolipid and Phospholipid Levels Are Altered in Human Brain in Chorea-Acanthocytosis”. Movement Disorders.
Fang, Tracy-Shi Zhang, You Sun, Andrew C Pierce, Simona Eleuteri, Mark Kemp, Christopher A Luckhurst, Rachel Williams, et al. 2023. “Knockout or Inhibition of USP30 Protects Dopaminergic Neurons in a Parkinson’s Disease Mouse Model”. Nature Communication.
2021
Simon, David K. 2021. “A New Approach to the Development of Disease-Modifying Therapies for PD”. Movement Disorders.
Baumgartner, Alexander J, Daniel Z. Press, and David K. Simon MD. 2021. “The Relationship Between Olfactory Dysfunction and Constipation in Early Parkinson’s Disease”. Movement Disorders.
2020
Simon, David K., Caroline M. Tanner, and Patrik Brundin. 2020. “Parkinson Disease Epidemiology, Pathology, Genetics, and Pathophysiology”. Clinical Geriatric Medicine.
Cutillo, G, DK Simon, and S Eleuteri. 2020. “VPS35 and Mitochondria: Connecting the Dots in Parkinson’s Disease Pathophysiology”. Neurobiology of Disease.
2019
Frank, Samuel, Sarah Berk, Laura Hernandez, Penelope Hogarth, Holly A Shill, Bernadette Siddiqi, and David K Simon. 2019. “Transportation Innovation to Aid Parkinson Disease Trial Recruitment”. Contemporary Clinical Trials Communications.